Dosage of rituximab in systemic sclerosis: 2-year results of five cases

Clin Exp Dermatol. 2015 Mar;40(2):211-2. doi: 10.1111/ced.12450. Epub 2014 Sep 23.

Authors

F C Moazedi-Fuerst¹, S M Kielhauser, K Bodo, W B Graninger

Affiliation

¹ Division of Rheumatology and Immunology, Medical University Graz Auenbruggerplatz, 15, 8036, Graz, Austria. florentine.fuerst@medunigraz.at.

PMID: 25250643
DOI: 10.1111/ced.12450

No abstract available

Publication types

Letter
Observational Study

MeSH terms

Antibodies, Monoclonal, Murine-Derived / administration & dosage*
Humans
Immunologic Factors / administration & dosage*
Rituximab
Scleroderma, Systemic / drug therapy*

Substances

Antibodies, Monoclonal, Murine-Derived
Immunologic Factors
Rituximab